Labrox

Uniogen—Enabling diagnosis and care at the first appointment. Our mission is to use advanced diagnostics to quickly identify pathogens and prevent their spread. Uniogen is a global pioneer in clinical diagnostics, point-of-care testing, and instrumentation for life sciences. Our mission is to enable diagnosis and care for patients at the first appointment. We are currently developing our first proprietary test, a unique glycovariant immunoassay, for the early detection of ovarian cancer. Uniogen was established when Abacus Diagnostica, a frontrunner in molecular testing and rapid PCR tests, Kaivogen, a specialist in immunoassays and antibody testing, and Labrox, an innovator of high-end laboratory instruments and diagnostic readers, joined forces in 2022. Uniogen’s products are sold in approximately 100 countries around the world. Uniogen’s new point-of-care testing solution under development will open great growth opportunities for us in the global diagnostics market.”.